含有功能性食品成分的膳食补充剂治疗勃起功能障碍的安全性和有效性

Seika Kamohara M.D., Ph.D , Masakatsu Kageyama , Satoshi Sunayama M.D., Ph.D , Kozo Denpo Ph.D
{"title":"含有功能性食品成分的膳食补充剂治疗勃起功能障碍的安全性和有效性","authors":"Seika Kamohara M.D., Ph.D ,&nbsp;Masakatsu Kageyama ,&nbsp;Satoshi Sunayama M.D., Ph.D ,&nbsp;Kozo Denpo Ph.D","doi":"10.1016/j.pmu.2014.03.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p><span>Functional food<span> ingredients are widely used for erectile dysfunction. We conducted 2 clinical studies to evaluate the safety and efficacy of a commercialized dietary supplement containing </span></span><span><em>Panax </em><em>ginseng</em></span> C.A. Meyer extract, <em>Lepidium meyenii</em> root extract, yeast extract, egg white peptide, <em>Mucuna pruriens</em><span> extract, black ginger extract, polyphenol, </span><span>l</span>-arginine, <span>l</span>-carnitine, coenzyme Q<sub>10</sub><span>, vitamin E, black pepper extract, and zinc.</span></p></div><div><h3>Methods</h3><p><span>In the first study, after providing informed consent, 15 healthy men (mean age, 35.3 ± 1.9 years) participated. A dietary supplement, EDiSON was administered for 8 weeks. Adverse events were recorded daily. In the second study, 14 men diagnosed with mild-to-moderate erectile dysfunction participated in an 8-week randomized, double-blind, placebo-controlled study. They were assigned to the dietary supplement group (</span><em>n</em> = 8) or the placebo group (<em>n</em><span> = 6). The primary outcome was the quality of life, as assessed by the International Index of Erectile Function-5 (IIEF-5) questionnaire.</span></p></div><div><h3>Results</h3><p>All patients completed the studies. In the first study, the intake of the dietary supplement was not associated with any adverse events. In the second study, the intake of the supplement was associated with significant improvement of the IIEF-5 score at 4 weeks and at 8 weeks of the trial, compared to the baseline.</p></div><div><h3>Conclusion</h3><p><span>Our initial findings support the safety of the EDiSON dietary supplement. The results from the randomized, double blind, placebo-controlled trial support the use of the EDiSON dietary supplement for the treatment of mild-to-moderate erectile dysfunction. This study was registered at </span><span>http://www.umin.ac.jp</span><svg><path></path></svg>, as UMIN000009405.</p></div>","PeriodicalId":101009,"journal":{"name":"Personalized Medicine Universe","volume":"3 ","pages":"Pages 38-41"},"PeriodicalIF":0.0000,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pmu.2014.03.002","citationCount":"6","resultStr":"{\"title\":\"Safety and efficacy of a dietary supplement containing functional food ingredients for erectile dysfunction\",\"authors\":\"Seika Kamohara M.D., Ph.D ,&nbsp;Masakatsu Kageyama ,&nbsp;Satoshi Sunayama M.D., Ph.D ,&nbsp;Kozo Denpo Ph.D\",\"doi\":\"10.1016/j.pmu.2014.03.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p><span>Functional food<span> ingredients are widely used for erectile dysfunction. We conducted 2 clinical studies to evaluate the safety and efficacy of a commercialized dietary supplement containing </span></span><span><em>Panax </em><em>ginseng</em></span> C.A. Meyer extract, <em>Lepidium meyenii</em> root extract, yeast extract, egg white peptide, <em>Mucuna pruriens</em><span> extract, black ginger extract, polyphenol, </span><span>l</span>-arginine, <span>l</span>-carnitine, coenzyme Q<sub>10</sub><span>, vitamin E, black pepper extract, and zinc.</span></p></div><div><h3>Methods</h3><p><span>In the first study, after providing informed consent, 15 healthy men (mean age, 35.3 ± 1.9 years) participated. A dietary supplement, EDiSON was administered for 8 weeks. Adverse events were recorded daily. In the second study, 14 men diagnosed with mild-to-moderate erectile dysfunction participated in an 8-week randomized, double-blind, placebo-controlled study. They were assigned to the dietary supplement group (</span><em>n</em> = 8) or the placebo group (<em>n</em><span> = 6). The primary outcome was the quality of life, as assessed by the International Index of Erectile Function-5 (IIEF-5) questionnaire.</span></p></div><div><h3>Results</h3><p>All patients completed the studies. In the first study, the intake of the dietary supplement was not associated with any adverse events. In the second study, the intake of the supplement was associated with significant improvement of the IIEF-5 score at 4 weeks and at 8 weeks of the trial, compared to the baseline.</p></div><div><h3>Conclusion</h3><p><span>Our initial findings support the safety of the EDiSON dietary supplement. The results from the randomized, double blind, placebo-controlled trial support the use of the EDiSON dietary supplement for the treatment of mild-to-moderate erectile dysfunction. This study was registered at </span><span>http://www.umin.ac.jp</span><svg><path></path></svg>, as UMIN000009405.</p></div>\",\"PeriodicalId\":101009,\"journal\":{\"name\":\"Personalized Medicine Universe\",\"volume\":\"3 \",\"pages\":\"Pages 38-41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.pmu.2014.03.002\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Personalized Medicine Universe\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2186495014000054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized Medicine Universe","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2186495014000054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

目的功能性食品成分被广泛用于治疗勃起功能障碍。我们进行了2项临床研究,以评估一种商业化膳食补充剂的安全性和有效性,该膳食补充剂含有人参C.A. Meyer提取物、Lepidium meyenii根提取物、酵母提取物、蛋清肽、Mucuna pruriens提取物、黑姜提取物、多酚、l-精氨酸、l-肉碱、辅酶Q10、维生素E、黑胡椒提取物和锌。方法在第一项研究中,在提供知情同意后,15名健康男性(平均年龄35.3±1.9岁)参与研究。作为一种膳食补充剂,爱迪生被给予8周。每天记录不良事件。在第二项研究中,14名被诊断为轻度至中度勃起功能障碍的男性参加了一项为期8周的随机、双盲、安慰剂对照研究。他们被分配到膳食补充剂组(n = 8)或安慰剂组(n = 6)。主要结果是生活质量,由国际勃起功能指数-5 (IIEF-5)问卷评估。结果所有患者均完成研究。在第一项研究中,摄入膳食补充剂与任何不良事件无关。在第二项研究中,与基线相比,在试验的第4周和第8周,补充剂的摄入与IIEF-5评分的显著改善有关。我们的初步研究结果支持EDiSON膳食补充剂的安全性。这项随机、双盲、安慰剂对照试验的结果支持使用EDiSON膳食补充剂治疗轻度至中度勃起功能障碍。本研究注册号为http://www.umin.ac.jp,编号为UMIN000009405。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Safety and efficacy of a dietary supplement containing functional food ingredients for erectile dysfunction

Purpose

Functional food ingredients are widely used for erectile dysfunction. We conducted 2 clinical studies to evaluate the safety and efficacy of a commercialized dietary supplement containing Panax ginseng C.A. Meyer extract, Lepidium meyenii root extract, yeast extract, egg white peptide, Mucuna pruriens extract, black ginger extract, polyphenol, l-arginine, l-carnitine, coenzyme Q10, vitamin E, black pepper extract, and zinc.

Methods

In the first study, after providing informed consent, 15 healthy men (mean age, 35.3 ± 1.9 years) participated. A dietary supplement, EDiSON was administered for 8 weeks. Adverse events were recorded daily. In the second study, 14 men diagnosed with mild-to-moderate erectile dysfunction participated in an 8-week randomized, double-blind, placebo-controlled study. They were assigned to the dietary supplement group (n = 8) or the placebo group (n = 6). The primary outcome was the quality of life, as assessed by the International Index of Erectile Function-5 (IIEF-5) questionnaire.

Results

All patients completed the studies. In the first study, the intake of the dietary supplement was not associated with any adverse events. In the second study, the intake of the supplement was associated with significant improvement of the IIEF-5 score at 4 weeks and at 8 weeks of the trial, compared to the baseline.

Conclusion

Our initial findings support the safety of the EDiSON dietary supplement. The results from the randomized, double blind, placebo-controlled trial support the use of the EDiSON dietary supplement for the treatment of mild-to-moderate erectile dysfunction. This study was registered at http://www.umin.ac.jp, as UMIN000009405.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A case of adverse skin reactions to coronavirus disease 2019 vaccine successfully treated with eppikajutsuto Dendritic Cell and Natural Killer cell stability for immunotherapy after long-term cryopreservation Cytokine-induced Neurogenesis for Alzheimer's Disease and Frontotemporal Dementia Airway stenting using Ultraflex for central airway stenosis due to lung cancer: A case report The role of regenerative invariant NKT cells in cancer immunotherapy for head and neck cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1